Challenges in Testing Intranasal Ketamine in Obsessive-Compulsive Disorder.
作者信息
Rodriguez Carolyn I, Lapidus Kyle A B, Zwerling Jordana, Levinson Amand, Mahnke Amanda, Steinman Shari A, Kalanthroff Eyal, Simpson Helen Blair
机构信息
Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, California, USA.
Veterans Affairs Palo Alto Health Care System, Palo Alto, California, USA.
出版信息
J Clin Psychiatry. 2017 Apr;78(4):466-467. doi: 10.4088/JCP.16cr11234.
Abstract
摘要
相似文献
1
Challenges in Testing Intranasal Ketamine in Obsessive-Compulsive Disorder.在强迫症中测试鼻内氯胺酮的挑战。
J Clin Psychiatry. 2017 Apr;78(4):466-467. doi: 10.4088/JCP.16cr11234.
2
Intranasal ketamine treatment in an adult with autism spectrum disorder.成年自闭症谱系障碍患者的鼻内氯胺酮治疗
J Clin Psychiatry. 2014 Aug;75(8):835-6. doi: 10.4088/JCP.13cr08917.
3
Rapid resolution of obsessions after an infusion of intravenous ketamine in a patient with treatment-resistant obsessive-compulsive disorder.一名难治性强迫症患者静脉输注氯胺酮后强迫观念迅速缓解。
J Clin Psychiatry. 2011 Apr;72(4):567-9. doi: 10.4088/JCP.10l06653.
4
Effects of Rapastinel (Formerly GLYX-13) on Serum Brain-Derived Neurotrophic Factor in Obsessive-Compulsive Disorder.瑞帕斯汀（原GLYX - 13）对强迫症患者血清脑源性神经营养因子的影响。
J Clin Psychiatry. 2018 Jan/Feb;79(1). doi: 10.4088/JCP.17l11824.
5
Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept.随机对照交叉试验氯胺酮治疗强迫症：概念验证。
Neuropsychopharmacology. 2013 Nov;38(12):2475-83. doi: 10.1038/npp.2013.150. Epub 2013 Jun 19.
6
Open-Label trial on the effects of memantine in adults with obsessive-compulsive disorder after a single ketamine infusion.美金刚对单次氯胺酮输注后成年强迫症患者影响的开放标签试验。
J Clin Psychiatry. 2016 May;77(5):688-9. doi: 10.4088/JCP.15l10318.
7
Can exposure-based CBT extend the effects of intravenous ketamine in obsessive-compulsive disorder? an open-label trial.基于暴露的认知行为疗法能否延长静脉注射氯胺酮治疗强迫症的效果？一项开放标签试验。
J Clin Psychiatry. 2016 Mar;77(3):408-9. doi: 10.4088/JCP.15l10138.
8
Ketamine followed by memantine for the treatment of major depression.氯胺酮后用美金刚治疗重度抑郁症。
Aust N Z J Psychiatry. 2008 Feb;42(2):170. doi: 10.1080/00048670701787628.
9
Intranasal Ketamine and Cognitive-Behavioral Therapy for Treatment-Refractory Obsessive-Compulsive Disorder.鼻内注射氯胺酮与认知行为疗法治疗难治性强迫症
J Clin Psychopharmacol. 2017 Apr;37(2):269-271. doi: 10.1097/JCP.0000000000000659.
10
Effects of ketamine in treatment-refractory obsessive-compulsive disorder.氯胺酮治疗难治性强迫症的效果。
Biol Psychiatry. 2012 Dec 1;72(11):964-70. doi: 10.1016/j.biopsych.2012.05.028. Epub 2012 Jul 10.
引用本文的文献
1
Agonism at mGluR2 receptors reduces dysfunctional checking on a rodent analogue of compulsive-like checking in obsessive compulsive disorder.代谢型谷氨酸受体2（mGluR2）受体激动作用可减少强迫症中类似强迫性检查行为的啮齿动物模型的功能失调性检查行为。
Psychopharmacology (Berl). 2025 Apr 3. doi: 10.1007/s00213-025-06774-2.
2
Ketamine for treatment-resistant obsessive-compulsive disorder: Double-blind active-controlled crossover study.氯胺酮治疗难治性强迫症：双盲活性对照交叉研究。
J Psychopharmacol. 2025 Jan;39(1):23-28. doi: 10.1177/02698811241301215. Epub 2024 Nov 28.
3
Therapeutic Potentials of Ketamine and Esketamine in Obsessive-Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature.氯胺酮和艾司氯胺酮在强迫症（OCD）、物质使用障碍（SUD）和饮食失调（ED）中的治疗潜力：当前文献综述
Brain Sci. 2021 Jun 27;11(7):856. doi: 10.3390/brainsci11070856.
4
Specialty knowledge and competency standards for pharmacotherapy for adult obsessive-compulsive disorder.成人强迫症药物治疗的专业知识和能力标准。
Psychiatry Res. 2021 Jun;300:113853. doi: 10.1016/j.psychres.2021.113853. Epub 2021 Mar 4.
5
Pharmacotherapy for Treatment-Resistant Obsessive-Compulsive Disorder.难治性强迫症的药物治疗
J Clin Psychiatry. 2020 Sep 8;81(5):19ac13182. doi: 10.4088/JCP.19ac13182.
6
Clinical advances in obsessive-compulsive disorder: a position statement by the International College of Obsessive-Compulsive Spectrum Disorders.强迫症临床进展：国际强迫症谱系及相关障碍学院立场声明。
Int Clin Psychopharmacol. 2020 Jul;35(4):173-193. doi: 10.1097/YIC.0000000000000314.
本文引用的文献
1
Open-Label trial on the effects of memantine in adults with obsessive-compulsive disorder after a single ketamine infusion.美金刚对单次氯胺酮输注后成年强迫症患者影响的开放标签试验。
J Clin Psychiatry. 2016 May;77(5):688-9. doi: 10.4088/JCP.15l10318.
2
Can exposure-based CBT extend the effects of intravenous ketamine in obsessive-compulsive disorder? an open-label trial.基于暴露的认知行为疗法能否延长静脉注射氯胺酮治疗强迫症的效果？一项开放标签试验。
J Clin Psychiatry. 2016 Mar;77(3):408-9. doi: 10.4088/JCP.15l10138.
3
A randomized controlled trial of intranasal ketamine in major depressive disorder.一项关于鼻内注射氯胺酮治疗重度抑郁症的随机对照试验。
Biol Psychiatry. 2014 Dec 15;76(12):970-6. doi: 10.1016/j.biopsych.2014.03.026. Epub 2014 Apr 3.
4
Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept.随机对照交叉试验氯胺酮治疗强迫症：概念验证。
Neuropsychopharmacology. 2013 Nov;38(12):2475-83. doi: 10.1038/npp.2013.150. Epub 2013 Jun 19.
5
Effects of ketamine in treatment-refractory obsessive-compulsive disorder.氯胺酮治疗难治性强迫症的效果。
Biol Psychiatry. 2012 Dec 1;72(11):964-70. doi: 10.1016/j.biopsych.2012.05.028. Epub 2012 Jul 10.
6
Rapid resolution of obsessions after an infusion of intravenous ketamine in a patient with treatment-resistant obsessive-compulsive disorder.一名难治性强迫症患者静脉输注氯胺酮后强迫观念迅速缓解。
J Clin Psychiatry. 2011 Apr;72(4):567-9. doi: 10.4088/JCP.10l06653.
7
Defining response in clinical trials for obsessive-compulsive disorder: a signal detection analysis of the Yale-Brown obsessive compulsive scale.强迫症临床试验中反应的定义：耶鲁-布朗强迫症量表的信号检测分析
J Clin Psychiatry. 2005 Dec;66(12):1549-57. doi: 10.4088/jcp.v66n1209.
8
A rating scale for depression.一种抑郁症评定量表。
J Neurol Neurosurg Psychiatry. 1960 Feb;23(1):56-62. doi: 10.1136/jnnp.23.1.56.
9
The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability.耶鲁-布朗强迫量表。I. 编制、使用及信度
Arch Gen Psychiatry. 1989 Nov;46(11):1006-11. doi: 10.1001/archpsyc.1989.01810110048007.
10
The Yale-Brown Obsessive Compulsive Scale. II. Validity.耶鲁-布朗强迫量表。II. 效度。
Arch Gen Psychiatry. 1989 Nov;46(11):1012-6. doi: 10.1001/archpsyc.1989.01810110054008.
Zotero 插件